What does LABORATOIRES S.M.B. do?

LABORATOIRES S.M.B. is registered with the CBE as active in: Vervaardiging van geneesmiddelen. Public Limited, started on 29 November 1978, 1 establishment.

What is the address of LABORATOIRES S.M.B.?

The registered office of LABORATOIRES S.M.B. is located at Herdersliedstraat 26-28, 1080 Sint-Jans-Molenbeek.

Is LABORATOIRES S.M.B. still active?

Yes. According to the CBE (29 October 2026) LABORATOIRES S.M.B. is active, legal situation “Normale toestand”, started on 29 November 1978.

Is LABORATOIRES S.M.B. registered on Peppol?

Yes, LABORATOIRES S.M.B. is registered on the Peppol network with ID 0208:0418956361.

What is the enterprise number of LABORATOIRES S.M.B.?

The enterprise number of LABORATOIRES S.M.B. is BE0418956361.

When was LABORATOIRES S.M.B. founded?

LABORATOIRES S.M.B. was founded on 29 November 1978.

Who are the directors of LABORATOIRES S.M.B.?

According to the 2025 annual accounts, the directors of LABORATOIRES S.M.B. are: CAROLINE BAUDIER, PHILIPPE BAUDIER.

Is LABORATOIRES S.M.B. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 November 1978; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did LABORATOIRES S.M.B. make in 2025?

LABORATOIRES S.M.B. posted a profit after taxes of € 19,990,441 in financial year 2025.

What is the revenue of LABORATOIRES S.M.B.?

In its most recent annual accounts (2025), LABORATOIRES S.M.B. reported revenue of € 112,458,586.

How much does an employee at LABORATOIRES S.M.B. earn?

The average wage cost per full-time employee at LABORATOIRES S.M.B. was € 94,800 in 2025: staff costs of € 3.8 million for 40 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does LABORATOIRES S.M.B. have?

According to the 2025 annual accounts, LABORATOIRES S.M.B. has 40 full-time equivalents (FTE).

LABORATOIRES S.M.B. (Public Limited)

Dossier LABORATOIRES S.M.B., printed on 29 October 2026 from databakkes.be/en/0418956361/laboratoires-s-m-b. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LABORATOIRES S.M.B. from Sint-Jans-Molenbeek, company number BE0418956361, closed financial year 2025 with a result of € 20 million after tax. For that financial year LABORATOIRES S.M.B. recorded revenue of € 112.5 million and equity of € 172.9 million. Compared with financial year 2024, the result moved from € 35.1 million to € 20 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.

What it is worth Healthy

€ 172.9 million

▼ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 20 million

▼ 43% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 18.7 million

▼ 55% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 60 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

▲ 1.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 25.3 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 3.8 million

▼ 17% vs 2024

€ 94,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 90,578

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 45,068

▲ 180% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 19.2 million

▲ 110% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 98 days on average.

Taxes and wages

€ 5.9 million

▲ € 5.3 million vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 92,840,928 Revenue 2022: € 92,840,928 First fiscal year in the series	€ 96,233,415 Revenue 2023: € 96,233,415 ▲ 4% vs 2022 (€ 92,840,928) Favourable step	€ 104,597,328 Revenue 2024: € 104,597,328 ▲ 9% vs 2023 (€ 96,233,415) Favourable step	€ 112,458,586 Revenue 2025: € 112,458,586 ▲ 8% vs 2024 (€ 104,597,328) Favourable step	▲ 8%
Profit after taxes	€ 56,125,243 Profit after taxes 2022: € 56,125,243 First fiscal year in the series	€ 34,488,285 Profit after taxes 2023: € 34,488,285 ▼ 39% vs 2022 (€ 56,125,243) Unfavourable step	€ 35,138,338 Profit after taxes 2024: € 35,138,338 ▲ 2% vs 2023 (€ 34,488,285) Favourable step	€ 19,990,441 Profit after taxes 2025: € 19,990,441 ▼ 43% vs 2024 (€ 35,138,338) Unfavourable step	▼ 43%
Equity	€ 182,372,228 Equity 2022: € 182,372,228 First fiscal year in the series	€ 205,626,513 Equity 2023: € 205,626,513 ▲ 13% vs 2022 (€ 182,372,228) Favourable step	€ 212,897,413 Equity 2024: € 212,897,413 ▲ 4% vs 2023 (€ 205,626,513) Favourable step	€ 172,887,854 Equity 2025: € 172,887,854 ▼ 19% vs 2024 (€ 212,897,413) Unfavourable step	▼ 19%
Total debts	€ 8,899,633 Total debts 2022: € 8,899,633 First fiscal year in the series	€ 10,491,691 Total debts 2023: € 10,491,691 ▲ 18% vs 2022 (€ 8,899,633) Unfavourable step	€ 28,496,504 Total debts 2024: € 28,496,504 ▲ 172% vs 2023 (€ 10,491,691) Unfavourable step	€ 85,159,845 Total debts 2025: € 85,159,845 ▲ 199% vs 2024 (€ 28,496,504) Unfavourable step	▲ 199%
Cash	€ 49,121,452 Cash 2022: € 49,121,452 First fiscal year in the series	€ 9,821,406 Cash 2023: € 9,821,406 ▼ 80% vs 2022 (€ 49,121,452) Unfavourable step	€ 41,235,074 Cash 2024: € 41,235,074 ▲ € 31.4 million vs 2023 (€ 9,821,406) Favourable step	€ 18,672,777 Cash 2025: € 18,672,777 ▼ 55% vs 2024 (€ 41,235,074) Unfavourable step	▼ 55%
Land & buildings	€ 262,167 Land & buildings 2022: € 262,167 First fiscal year in the series	€ 283,169 Land & buildings 2023: € 283,169 ▲ 8% vs 2022 (€ 262,167) Unchanged	€ 321,372 Land & buildings 2024: € 321,372 ▲ 13% vs 2023 (€ 283,169) Unchanged	€ 301,818 Land & buildings 2025: € 301,818 ▼ 6% vs 2024 (€ 321,372) Unchanged	▼ 6%
Retained profit	€ 180,168,455 Retained profit 2022: € 180,168,455 First fiscal year in the series	€ 203,422,740 Retained profit 2023: € 203,422,740 ▲ 13% vs 2022 (€ 180,168,455) Favourable step	€ 210,693,640 Retained profit 2024: € 210,693,640 ▲ 4% vs 2023 (€ 203,422,740) Favourable step	€ 170,684,081 Retained profit 2025: € 170,684,081 ▼ 19% vs 2024 (€ 210,693,640) Unfavourable step	▼ 19%
Dividend	€ 25,000,000 Dividend 2022: € 25,000,000 First fiscal year in the series	€ 11,234,000 Dividend 2023: € 11,234,000 ▼ 55% vs 2022 (€ 25,000,000) Unchanged	€ 17,467,439 Dividend 2024: € 17,467,439 ▲ 55% vs 2023 (€ 11,234,000) Unchanged	€ 60,000,000 Dividend 2025: € 60,000,000 ▲ 243% vs 2024 (€ 17,467,439) Unchanged	▲ 243%
Bank debt	€ 2,144 Bank debt 2022: € 2,144 First fiscal year in the series	€ 32,408 Bank debt 2023: € 32,408 ▲ € 30,264 vs 2022 (€ 2,144) Unfavourable step	€ 16,078 Bank debt 2024: € 16,078 ▼ 50% vs 2023 (€ 32,408) Favourable step	€ 45,068 Bank debt 2025: € 45,068 ▲ 180% vs 2024 (€ 16,078) Unfavourable step	▲ 180%
Balance sheet total	€ 191,567,847 Balance sheet total 2022: € 191,567,847 First fiscal year in the series	€ 216,610,807 Balance sheet total 2023: € 216,610,807 ▲ 13% vs 2022 (€ 191,567,847) Unchanged	€ 241,886,520 Balance sheet total 2024: € 241,886,520 ▲ 12% vs 2023 (€ 216,610,807) Unchanged	€ 261,502,210 Balance sheet total 2025: € 261,502,210 ▲ 8% vs 2024 (€ 241,886,520) Unchanged	▲ 8%
Employees (FTE)	42.3 Employees (FTE) 2022: 42.3 First fiscal year in the series	40.2 Employees (FTE) 2023: 40.2 ▼ 2.1 vs 2022 (42.3) Unchanged	38.7 Employees (FTE) 2024: 38.7 ▼ 1.5 vs 2023 (40.2) Unchanged	40 Employees (FTE) 2025: 40 ▲ 1.3 vs 2024 (38.7) Unchanged	▲ 1.3

Key figures of LABORATOIRES S.M.B., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LABORATOIRES S.M.B.?

What happened at LABORATOIRES S.M.B. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 PHILIPPE BAUDIER stepped down as director. NBB
2026 CAROLINE BAUDIER stepped down as director. NBB
Sep 25, 2026 New annual accounts for financial year 2025: profit of € 20 million (▼ 43% vs 2024). filed late Source: NBB ↗
2024 PHILIPPE BAUDIER became a director. NBB
2020 CAROLINE BAUDIER became a director. NBB
Nov 29, 1978 New establishment in Sint-Jans-Molenbeek. KBO
Nov 29, 1978 Start of the company according to the CBE. KBO

In short

From € 56.1 million profit in 2022 to € 20 million profit in 2025.

Paid € 18.8 million in corporate taxes since 2022.

Best year ever: 2022, with € 56.1 million profit.

Paid out € 113.7 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

PHARLYSE

LABORATOIRES S.M.B.

SMB TECHNOLOGY 16%

The shares are held by PHARLYSE. It owns 16% of SMB TECHNOLOGY itself.

Directors

According to the 2025 annual accounts

CAROLINE BAUDIER

Managing director

since 2020 · until 2026

PHILIPPE BAUDIER

Managing director

since 2024 · until 2030

Shareholders

PHARLYSE

Participations

SMB TECHNOLOGY

16%

Establishments

Establishment units

Physical locations of this company

Registered office

Herdersliedstraat 26-28

1080 Sint-Jans-Molenbeek

2.015.751.555

Herdersliedstraat 26 28

1080 Sint-Jans-Molenbeek

Active since 29 November 1978

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0418.956.361
VAT number: BE 0418.956.361
Registered office: Herdersliedstraat 26-28, 1080 Sint-Jans-Molenbeek
Names & denominations: LABORATOIRES S.M.B.
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 29 November 1978
Peppol: Active · Active since 21 Oct 2026
Activities · NACE: Vervaardiging van geneesmiddelen

View on CBE Public ↗ Annual accounts (NBB) ↗